Back

In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study

28 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes Inflammation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yu-Jen Wang

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

7 More presentations in this session

Presentation thumbnail
The association between the hsCRP/BMI ratio and cardiovascular prognosis in CAD patients
Doctor J. Yang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Association of inflammatory activation with acute stent thrombosis
Doctor K. Krychtiuk (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The influence of early post-STEMI inflammation on diastolic function: diagnostic and therapeutic implications
Doctor S. Filip (Lyon, FR)
Abstract Slides Video
Presentation thumbnail
Helicobacter pylori and pro-inflammatory protein biomarkers in myocardial infarction with and without obstructive coronary artery disease
Doctor J. Warme (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of the infarct-related coronary artery on inflammatory profiles and outcomes in patients presenting with acute coronary syndromes: insights from a prospective multicenter real-world cohort
Doctor F. Bruno (Turin, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Session
Markers of inflammation and outcomes in patients with acute coronary syndromes
thumbnail
Congress Presentation
Interleukin-8 plasma levels correlate with changes in coronary atherosclerosis in patients with acute myocardial infarction treated with alirocumab
thumbnail
Congress Presentation
Prognostic value of IL-22 levels and the TH17 pathway in patients with acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources